Facebook
Twitter
LinkedIn
Forward| Title | Program description | Type | Credit | Event date |
|---|---|---|---|---|
| Multidisciplinary Cutaneous Oncology Symposium 2024 |
September 27 - 28, 2024 - The Ritz-Carlton Orlando, Grande Lakes - Orlando, Florida This course offers Live (in-person) and Livestream (virtual) attendance options. Mayo Clinic's 8th Annual Multidisciplinary Cutaneous Oncology Symposium in Orlando, Florida is a two-day CME course focused on the latest topics in cutaneous oncology covering the fields of dermatology, surgical oncology, radiation oncology and medical oncology. The goal of this symposium is to discuss the available evidence of these topics to assist in making the most informed decisions. In addition, numerous presentations and discussions will highlight current and new advances in therapeutic treatments for both melanoma and non-melanoma skin cancers, especially, basal cell, squamous cell and Merkel cell carcinoma. |
Live | 09/27/2024 to 09/28/2024 | |
| Principles in the Care of Transgender and Intersex Patients 2024 |
October 17 - 19, 2024 - Hilton La Jolla Torrey Pines - La Jolla, California This course offers Live (in-person) and Livestream (virtual) attendance options In the last several years, healthcare providers have seen an influx of transgender and intersex people seeking sensitive and appropriate care. This pioneering course offers cutting-edge perspectives and practical evidence-based principles for working with transgender and intersex individuals. Experts from Mayo Clinic's Transgender and Intersex Specialty Care Clinic instruct attendees in medical, surgical, psychosocial, legal and ethical issues in transgender and intersex care. Participants leave with the knowledge and skills to provide gender-affirming care across settings. |
Live | 10/17/2024 to 10/19/2024 | |
| Multidisciplinary Update in Breast Disease 2024 |
November 7 - 9, 2024 - Hilton La Jolla Torrey Pines - La Jolla, California This course offers Live (in-person) and Livestream (virtual) attendance options This two-and-a-half-day continuing medical education course provides a multidisciplinary update in prevention, evaluation, diagnosis, management, and treatment of benign and malignant breast diseases, and high risk and survivorship issues. The course has multidisciplinary experts in their field presenting the latest, diagnostic, treatment and management options. Highlights include, genetics and high-risk management, breast imaging modalities, supplemental screening options for dense breasts, and more. |
Live | 11/07/2024 to 11/09/2024 | |
| Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2024 |
November 8 - 9, 2024 - The Venetian Resort This course offers Live (in-person) and Livestream (virtual) attendance options The 2024 Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium will provide a multidisciplinary overview on the importance of early diagnosis and treatment considerations, including surgery, radiation, loco-regional approaches, and systemic therapies. Nationally and internationally renowned faculty will offer state-of-the-art updates on current treatment options for patients with hepato-pancreatico-biliary cancers. This timely education will be delivered through case-based discussions, interactive Q&A, and didactic presentations. |
Live | 11/08/2024 to 11/09/2024 | |
| Mayo Clinic Multidisciplinary Head and Neck Cancer Symposium 2025 |
March 27 - 29, 2025 - The Scottsdale Plaza Resort & Villas - Scottsdale, Arizona This course offers Live (in-person) and Livestream (virtual) attendance options Mayo Clinic’s multidisciplinary head and neck symposium offers the latest advances in head and neck cancer in the fields of surgical oncology, radiation oncology, and medical oncology. Also, current information about symptom control and survivorship is discussed. This unique symposium offers two days of multidisciplinary sessions and one day of subspecialty paths with highly engaging group discussions. The primary goal of this course is to guide practitioners and allied health staff on the best evidence-based care for patients with head and neck cancers. |
Live | 03/27/2025 to 03/29/2025 |